Meeting
2018 Gastrointestinal Cancers Symposium
Role of adjuvant therapy in resected gallbladder cancer.
Authors
Mohamed Abdelrahim Muddathir Hassan
Mayo Clinic, Rochester, MN
Mohamed Abdelrahim Muddathir Hassan , Nicha Wongjarupong , Cristobal T. Sanhueza , Mindy L. Hartgers , Fatima Hassan , Lewis R. Roberts , Amit Mahipal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 452)
DOI
10.1200/JCO.2018.36.4_suppl.452
Abstract #
452
Poster Bd #
L23
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real-world treatments and outcomes of resected biliary tract cancers in British Columbia, Canada.
First Author: Mélina Boutin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A randomized, multi-center phase III trial of adjuvant chemotherapy with gemcitabine and capecitabine (GemCap) compared to capecitabine (Cap) alone in curatively resected biliary tract cancer (BilGemCap Study): KCSG HB20-14.
First Author: Joon Oh Park
Poster
2019 Gastrointestinal Cancers Symposium
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.
First Author: Sakti Chakrabarti
Poster
2018 Gastrointestinal Cancers Symposium
Is there any survival benefit of additional chemotherapy (C) following adjuvant C in pancreatic cancer (PC) patients (pts) with postsurgery elevated CA19-9?
First Author: Wasif M. Saif